MedRx Co., Ltd (TYO:4586)
65.00
0.00 (0.00%)
May 29, 2026, 3:30 PM JST
MedRx Market Cap
MedRx has a market cap or net worth of 3.86 billion as of May 29, 2026. Its market cap has increased by 24.99% in one year.
Market Cap
3.86B
Enterprise Value
2.40B
Revenue
131.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.00
Market Cap Chart
Since February 13, 2013, MedRx's market cap has decreased from 11.76B to 3.86B, a decrease of -67.19%. That is a compound annual growth rate of -8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.86B | -39.81% |
| Dec 30, 2025 | 6.41B | 65.15% |
| Dec 30, 2024 | 3.88B | -32.98% |
| Dec 29, 2023 | 5.79B | 117.37% |
| Dec 30, 2022 | 2.67B | -15.34% |
| Dec 30, 2021 | 3.15B | -20.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharma Foods International | 18.67B |
| Fuso Pharmaceutical Industries,Ltd. | 17.35B |
| Taiko Pharmaceutical | 12.86B |
| Wakamoto Pharmaceutical | 9.78B |
| Morishita Jintan | 8.86B |
| Solasia Pharma K.K. | 6.55B |
| WDB coco | 6.18B |
| Nippon Chemiphar | 5.88B |